Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationLymphomaLiver TransplantationTransplantation ConditioningLymphoma, Non-HodgkinStem Cell TransplantationMultiple MyelomaKidney TransplantationMelphalanHematopoietic Stem Cell MobilizationTreatment OutcomeGraft SurvivalPeripheral Blood Stem Cell TransplantationCombined Modality TherapyLymphoma, B-CellCell TransplantationHeart TransplantationSalvage TherapyAntigens, CD34Bone Marrow PurgingLung TransplantationRecurrenceCyclophosphamideCarmustineAntineoplastic Combined Chemotherapy ProtocolsHodgkin DiseaseRemission InductionLeukapheresisGranulocyte Colony-Stimulating FactorGraft vs Host DiseaseWhole-Body IrradiationLymphoma, T-CellHematopoietic Stem CellsRetrospective StudiesDisease-Free SurvivalLymphoma, Large B-Cell, DiffuseSurvival AnalysisEtoposideOrgan TransplantationBusulfanHematologic NeoplasmsSurvival RateLymphoma, FollicularBlood Transfusion, AutologousTime FactorsGraft RejectionCytarabineImmunosuppressive AgentsFollow-Up StudiesPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsVincristineTransplantationTransplantation ImmunologyGraft vs Tumor EffectBone MarrowMyeloablative AgonistsBurkitt LymphomaPrognosisTransplantation ChimeraThalidomidePrednisoneKanamycin KinaseFeasibility StudiesAntibodies, Monoclonal, Murine-DerivedTransplantation, IsogeneicBlood Component RemovalNeoplasm, ResidualLeukemiaLymphoma, B-Cell, Marginal ZoneCells, CulturedCell SeparationDoxorubicinHematopoiesisLiving DonorsGenetic TherapyTransplantation, HeterotopicCord Blood Stem Cell TransplantationIdarubicinAntineoplastic Agents, AlkylatingAntibodies, MonoclonalBone Marrow CellsDexamethasoneHeart-Lung TransplantationLeukemia, Myeloid, AcuteProspective StudiesMyelodysplastic SyndromesLymphoma, Mantle-CellColony-Forming Units AssayStem CellsImmunomagnetic SeparationBlood Cell CountAntineoplastic AgentsImmunosuppressionPostoperative ComplicationsCell Culture Techniques